The proposed NIH policy to cap indirect costs on research grants at 15% would strain academic medical centers (AMCs) and universities that rely on these funds to support essential infrastructure.

In today’s volatile healthcare landscape, CFOs are being called to step beyond traditional financial management and embrace a transformative leadership role.

In conversations with hospital boards and C-suite leaders, a question frequently raised is: “Given such difficult operating circumstances, why are some hospitals successfully managing through – and others are not?”

Assessing the future of healthcare price transparency requires taking a couple of steps back to review its recent history.

This week’s graphic highlights data from a recent study published by The Lancet on cancer incidence trends in the United States between 2000 and 2019 among those born between 1920 and 1990. Of the 34 types of cancer studied, 17 were found to have an increased incidence among those from the Generation X and Millennial cohorts

Trump pauses tariffs, House OK’s budget blueprint, CMS sets 2025 MA rate

The hospital and health system leaders we work with are extremely concerned about the financial impact their organizations may experience from potentially significant Medicaid policy changes, following the recent passage of a budget resolution by the U.S. House of Representatives.

Possible limitations on state directed payment programs could have a significant impact on many hospitals’ bottom line. Organizations should act now to model the impact and identify steps that could help mitigate it.

Cybersecurity remains a top concern for many healthcare organizations as attacks continue to increase.

Performance in February has remained stable. Volumes stayed strong, including in emergency departments. Non-labor expenses have been the primary driver of expense growth thus far in 2025.

Only five hospital and health system M&A transactions were announced in Q1 2025, reflecting an environment of economic uncertainty and volatility. Financial distress was a driver in many of the announced transactions, continuing a trend from 2024.